ArticleTheranostics2018
Ultrahigh-resolution optical coherence microscopy accurately classifies precancerous and cancerous human cervix free of labeling.
Article in Theranostics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Deep Learning and Attention Mechanism-based Prediction of Vaginal Invasion in Early-Stage Cervical CancerCurrent medical imaging · 2026Article
- ChatOCT: Embedded Clinical Decision Support Systems for Optical Coherence Tomography in Offline and Resource-Limited Settings.Journal of medical systems · 2025Article
- In situ expansion capacity evaluation of terminal alveoli in chronic obstructive pulmonary disease using an ultrathin optical coherence tomography catheter.Biomedical optics express · 2025Article
- Unveiling the mysteries of extrachromosomal circular DNA: from generation to clinical relevance in human cancers and health.Molecular cancer · 2024Review
- A Deep Learning Model for Cervical Optical Coherence Tomography Image Classification.Diagnostics (Basel, Switzerland) · 2024Article
- Usability of a smartphone-compatible, confocal micro-endoscope for cervical cancer screening in resource-limited settings.BMC women's health · 2024Article
- Optical imaging for screening and early cancer diagnosis in low-resource settings.Nature reviews bioengineering · 2024Article
- Clinical value of optical coherence tomography in the early diagnosis of cervical cancer and precancerous lesions: a cross-sectional study.Frontiers in oncology · 2024Article
- Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer.Infectious agents and cancer · 2023Article
- Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.PloS one · 2023Article
- Development of a multimodal mobile colposcope for real-time cervical cancer detection.Biomedical optics express · 2022Article
- Study on the application and imaging characteristics of optical coherence tomography in vulva lesions.Scientific reports · 2022Article
- Research progress on the application of optical coherence tomography in the field of oncology.Frontiers in oncology · 2022Review
- Millimeter-scale chip-based supercontinuum generation for optical coherence tomography.Science advances · 2021Article
- Multi-center clinical study using optical coherence tomography for evaluation of cervical lesions in-vivo.Scientific reports · 2021Article
- SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury.Aging · 2020Article
- Real-time colorectal cancer diagnosis using PR-OCT with deep learning.Theranostics · 2020Article
- Computer-Aided Diagnosis of Label-Free 3-D Optical Coherence Microscopy Images of Human Cervical Tissue.IEEE transactions on bio-medical engineering · 2019Article
- Advances in technologies for cervical cancer detection in low-resource settings.Expert review of molecular diagnostics · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Cervical cancer remains the fourth most common cause of cancer worldwide and the third leading cause of cancer deaths for women in developing countries. Traditional screening tools, such as human papillomavirus and Pap tests, cannot provide results in real-time and cannot localize suspicious regions. Colposcopy-directed biopsies are invasive in nature and only a few sites of the cervix may be chosen for investigation. A non-invasive, label-free and real-time imaging method with a resolution approaching that of histopathology is desirable for early detection of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.